AAAAAA
Results:
1-12
|
Results: 12
Authors:
KATABAMI M
DOSAKAAKITA H
HONMA K
KIMURA K
FUJINO M
UCHIDA Y
MIKAMI H
OHSAKI Y
KAWAKAMI Y
KIKUCHI K
Citation: M. Katabami et al., P53 AND BCL-2 EXPRESSION IN PNEUMOCONIOSIS-RELATED PRECANCEROUS LESIONS AND LUNG CANCERS - FREQUENT AND PREFERENTIAL P53 EXPRESSION IN PNEUMOCONIOTIC BRONCHIOLAR DYSPLASIAS, International journal of cancer, 75(4), 1998, pp. 504-511
Authors:
DOSAKAAKITA H
HOMMURA F
FUJITA H
KINOSHITA I
NISHI M
MORIKAWA T
KATOH H
KAWAKAMI Y
KUZUMAKI N
Citation: H. Dosakaakita et al., FREQUENT LOSS OF GELSOLIN EXPRESSION IN NONSMALL CELL LUNG CANCERS OFHEAVY SMOKERS, Cancer research, 58(2), 1998, pp. 322-327
Authors:
DOSAKAAKITA H
MIYAMOTO H
NAKABAYASHI T
SASAKI S
ARIMOTO T
MIYASAKA K
SHIMIZU T
KAWAKAMI Y
Citation: H. Dosakaakita et al., CONCURRENT CHEMOTHERAPY AND THORACIC RADIATION-THERAPY FOR LIMITED-STAGE SMALL-CELL LUNG-CANCER, International journal of oncology, 11(2), 1997, pp. 371-375
Authors:
ISHIKURO A
DOSAKAAKITA H
KATO M
FUJINO M
ISOBE H
MIYAMOTO H
INOUE K
KAWAKAMI Y
Citation: A. Ishikuro et al., KI-67 LABELING INDEXES IN NONSMALL CELL LUNG-CANCER - COMPARISON BETWEEN IMAGE CYTOMETRY AND FLOW-CYTOMETRY, Cytometry, 30(4), 1997, pp. 186-191
Authors:
DOSAKAAKITA H
HU SX
FUJINO M
HARADA M
KINOSHITA I
XU HJ
KUZUMAKI N
KAWAKAMI Y
BENEDICT WF
Citation: H. Dosakaakita et al., ALTERED RETINOBLASTOMA PROTEIN EXPRESSION IN NONSMALL CELL LUNG-CANCER - ITS SYNERGISTIC EFFECTS WITH ALTERED RAS AND P53 PROTEIN STATUS ONPROGNOSIS, Cancer, 79(7), 1997, pp. 1329-1337
Authors:
HANADA T
OGURA S
ISOBE H
DOSAKAAKITA H
YAMAZAKI K
WATANABE N
KAWAKAMI Y
Citation: T. Hanada et al., WEB-LIKE OBSTRUCTION - A SIGN OF REGIONAL COMPLETE REMISSION AFTER CONCURRENT CHEMORADIOTHERAPY IN SMALL-CELL LUNG-CANCER, Internal medicine, 35(9), 1996, pp. 732-735
Authors:
KINOSHITA I
DOSAKAAKITA H
MISHINA T
AKIE K
NISHI M
HIROUMI H
HOMMURA F
KAWAKAMI Y
Citation: I. Kinoshita et al., ALTERED P16(INK4) AND RETINOBLASTOMA PROTEIN STATUS IN NONSMALL CELL LUNG-CANCER - POTENTIAL SYNERGISTIC EFFECT WITH ALTERED P53 PROTEIN ONPROLIFERATIVE ACTIVITY, Cancer research, 56(24), 1996, pp. 5557-5562
Authors:
DOSAKAAKITA H
AKIE K
HIROUMI H
KINOSHITA I
KAWAKAMI Y
MURAKAMI A
Citation: H. Dosakaakita et al., INHIBITION OF PROLIFERATION BY L-MYC ANTISENSE DNA FOR THE TRANSLATIONAL INITIATION SITE IN HUMAN SMALL-CELL LUNG-CANCER, Cancer research, 55(7), 1995, pp. 1559-1564
Authors:
FUJINO M
DOSAKAAKITA H
HARADA M
HIROUMI H
KINOSHITA I
AKIE K
KAWAKAMI Y
Citation: M. Fujino et al., PROGNOSTIC-SIGNIFICANCE OF P53 AND RAS P21 EXPRESSION IN NONSMALL CELL LUNG-CANCER, Cancer, 76(12), 1995, pp. 2457-2463
Authors:
KINOSHITA I
DOSAKAAKITA H
SHINDOH M
FUJINO M
AKIE K
KATO M
FUJINAGA K
KAWAKAMI Y
Citation: I. Kinoshita et al., HUMAN PAPILLOMAVIRUS TYPE-18 DNA AND E6-E7 MESSENGER-RNA ARE DETECTEDIN SQUAMOUS-CELL CARCINOMA AND ADENOCARCINOMA OF THE LUNG, British Journal of Cancer, 71(2), 1995, pp. 344-349
Authors:
FUJINO M
DOSAKAAKITA H
KATO M
KINOSHITA I
AKIE K
KAWAKAMI Y
Citation: M. Fujino et al., SIMULTANEOUS USE OF THE PCR-SSCP METHOD AND IMMUNOHISTOCHEMISTRY FOR INCREASING THE DETECTION EFFICACY OF P53 ABNORMALITIES IN HUMAN LUNG-CANCER, American journal of clinical pathology, 104(3), 1995, pp. 319-324
Authors:
DOSAKAAKITA H
SHINDOH M
FUJINO M
KINOSHITA I
AKIE K
KATOH M
KAWAKAMI Y
Citation: H. Dosakaakita et al., ABNORMAL P53 EXPRESSION IN HUMAN LUNG-CANCER IS ASSOCIATED WITH HISTOLOGIC SUBTYPES AND PATIENT SMOKING HISTORY, American journal of clinical pathology, 102(5), 1994, pp. 660-664
Risultati:
1-12
|